Pegadricase

聚乙二醇化重组假丝酵母尿酸氧化酶

Report date: 2025/08/05 20:00:05

Base Information

Drug NamePegadricase
Drug Alias NamePegsitacasePegsiticaseSEL 037Uricase-PEG 20SSS-11
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUric acid stimulants
TargetsUric acid
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPolaris Group Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesPolaris Group LtdShenyang Sunshine Pharmaceutical Co Ltd
Inactive CompaniesEnzymerx LlcSelecta Biosciences Inc
Active IndicationsHyperuricemiaGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG